Literature DB >> 9321743

Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with hypertension.

J R Jeng1, S M Shieh, H J Harn, M M Lee, W H Sheu, C Y Jeng.   

Abstract

BACKGROUND: The homozygote deletion (DD) genotype of the angiotensin I converting enzyme (ACE) gene has been shown to be associated with an increased risk of coronary heart disease independent of other risk factors.
OBJECTIVE: To investigate the possible association of the insertion/deletion (I/D) polymorphism of the ACE gene with insulin resistance in a Chinese population with and without hypertension. SUBJECTS AND METHODS: The I/D polymorphism of the ACE gene was determined for 361 Chinese including 148 women and 96 men with normal blood pressures and 64 male and 53 female patients with mild-to-moderate hypertension. Insulin resistance was estimated by the insulin suppression test and glucose intolerance evaluated with an oral glucose-tolerance test for all of the subjects.
RESULTS: Three hypertensive subgroups with DD, DI and II genotypes having similar ages and body mass indexes presented insignificantly different degrees of glucose intolerance and insulin resistance both among men and among women. Similar results were found for normotensive subjects. In addition, ACE genotypes were not significant predictors of insulin resistance and glucose intolerance either among men or among women after adjustment for age, body mass index, and hypertension.
CONCLUSION: The present data indicated that the I/D polymorphism of the ACE gene was not related to insulin resistance for Chinese hypertensive and normotensive subjects. The increased risk of coronary heart disease associated with the DD genotype need not be mediated through the mechanism of insulin resistance and glucose intolerance for Chinese patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9321743     DOI: 10.1097/00004872-199715090-00006

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

Review 1.  Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Authors:  André J Scheen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  The impact of the angiotensin-converting enzyme insertion/deletion polymorphism on severe hypoglycemia in Type 2 diabetes.

Authors:  Rachel M Freathy; Kathryn F Lonnen; Anna M Steele; Jayne A L Minton; Timothy M Frayling; Andrew T Hattersley; Kenneth M Macleod
Journal:  Rev Diabet Stud       Date:  2006-08-10

3.  Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise-mediated changes in Korean women.

Authors:  Kijin Kim
Journal:  Eur J Appl Physiol       Date:  2009-01-06       Impact factor: 3.078

4.  Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes.

Authors:  Rita Schüler; Martin A Osterhoff; Turid Frahnow; Matthias Möhlig; Joachim Spranger; Darko Stefanovski; Richard N Bergman; Li Xu; Anne-Cathrin Seltmann; Stefan Kabisch; Silke Hornemann; Michael Kruse; Andreas F H Pfeiffer
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.